Biomimetic Nanovesicles-Sources, Design, Production Methods, and Applications

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery Systems

Background:

• Current liposomes and nanoparticles have limitations in drug and gene delivery, including poor targeting and immune system evasion.
• Synthetic carriers often suffer from short circulation times, cytotoxicity, and challenges in crossing biological barriers.
• Biological vesicles possess inherent properties beneficial for drug delivery, such as effective targeting and immune system interaction.

Purpose of the Study:

• To explore biomimetic nanovesicles (BNV) as an advanced strategy to overcome limitations of synthetic drug and gene delivery systems.
• To review research on BNV for drug delivery, gene delivery, and vaccine applications.
• To discuss sources, production methods, and hybridization potential of BNV.

Main Methods:

• Review of existing research on biomimetic nanovesicles (BNV) in drug and gene delivery.
• Analysis of natural vesicle sources and their technical isolation/production methods.
• Exploration of hybrid BNV systems combining natural and synthetic components.

Main Results:

• Biomimetic nanovesicles (BNV) integrate natural vesicle advantages with synthetic system control.
• BNV show potential for enhanced targeting, immune system escape, and improved circulation time.
• Advancements in biotechnology and nanotechnology facilitate BNV design and production.

Conclusions:

• Biomimetic nanovesicles (BNV) represent a significant advancement over traditional synthetic carriers.
• BNV are poised to address key challenges in drug delivery, gene therapy, and vaccine development.
• Further research into BNV hybridization offers expanded therapeutic possibilities.